Bridging Therapy With Axicabtagene Ciloleucel for LBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: Results from the US lymphoma CAR-T consortium
Blood Adv 2023 Nov 16;[EPub Ahead of Print], MD Jain, MT Jacobs, F Gao, LJ Nastoupil, JY Spiegel, Y Lin, S Dahiya, MA Lunning, LJ Lekakis, PM Reagan, OO Oluwole, JP McGuirk, A Deol, A Sehgal, A Goy, BT Hill, C Andreadis, J Munoz, JC Chavez, NN Bennani, AP Rapoport, JM Vose, DB Miklos, SS Neelapu, FL Locke, A GhobadiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.